NCT02232542View on ClinicalTrials.gov

Tolerability and Safety of Duloxetine BID in Healthy Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

August 31, 2003

Conditions
Healthy
Interventions
DRUG

Duloxetine - low dose

DRUG

Duloxetine - high dose

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02232542 - Tolerability and Safety of Duloxetine BID in Healthy Female Subjects | Biotech Hunter | Biotech Hunter